U.S. to donate 500M doses of Pfizer-BioNTech COVID-19 vaccines

By The Science Advisory Board staff writers

June 10, 2021 -- The U.S. government is buying 500 million doses of the Pfizer-BioNTech COVID-19 vaccine to distribute to low- and lower middle-income countries and organizations that support them, according to a release from the companies.

The U.S. government will purchase 200 million doses in 2021 and 300 million in the first half of 2022 at a nonprofit price and will distribute the vaccine doses to 92 low- and lower middle-income countries and economies and the 55 member states of the African Union. The U.S. government and the companies will work with Covax to ensure these vaccines are delivered to the specified countries around the world in a way that is most efficient and equitable, Pfizer said.

These doses are part of Pfizer and BioNTech's previously announced pledge to provide 2 billion doses of the COVID-19 vaccine to low- and middle-income countries over the next 18 months.

MilliporeSigma scales up lipid production for COVID-19 vaccines
MilliporeSigma announced that it has launched a new high-purity synthetic cholesterol product to meet demand for lipids, a component of messenger RNA-based...
Pfizer to study pneumococcal, COVID-19 vaccine combo in older adults
Pfizer has launched a study that is investigating the coadministration of the company's pneumococcal vaccine (20vPnC) and its Pfizer-BioNTech COVID-19...
FDA authorizes Pfizer-BioNTech COVID-19 vaccine for adolescents
The U.S. Food and Drug Administration (FDA) expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to include adolescents...
Pfizer, BioNTech initiate rolling submission of BLA for COVID-19 vaccine
Pfizer and BioNTech announced on Friday that they have started a biologics license application (BLA) with the U.S. Food and Drug Administration for approval...
Pfizer, BioNTech submit expanded CMA to EMA for COVID-19 vaccine
Pfizer and BioNTech announced on Friday they have submitted a variation to the conditional marketing authorization (CMA) for use of their COVID-19 vaccine...

Copyright © 2021 scienceboard.net


Conferences
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter